Not all stage I and II endometrial cancers are created equal: Recurrence-free survival and cause-specific survival after observation or vaginal brachytherapy alone in all subgroups of early-stage high-intermediate and high-risk endometrial cancer.
Autor: | Garzon, Simone1 (AUTHOR), Grassi, Tommaso1 (AUTHOR), Mariani, Andrea1 (AUTHOR), Kollikonda, Swapna2 (AUTHOR), Weaver, Amy L.3 (AUTHOR), McGree, Michaela E.3 (AUTHOR), Petersen, Ivy A.4 (AUTHOR), Weroha, S. John5 (AUTHOR), Glaser, Gretchen E.1 (AUTHOR), Langstraat, Carrie L.1 (AUTHOR), Amarnath, Sudha R.6 (AUTHOR), AlHilli, Mariam M.1,7 (AUTHOR) ALHILLM@ccf.org |
---|---|
Zdroj: | Gynecologic Oncology. Dec2022, Vol. 167 Issue 3, p444-451. 8p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |